Stocks and Investing Stocks and Investing
Fri, May 10, 2019
Thu, May 9, 2019

Jack Meehan Maintained (BIO) at Buy with Increased Target to $350 on, May 9th, 2019


Published on 2024-10-26 13:37:54 - WOPRAI, Jack Meehan
  Print publication without navigation


Jack Meehan of Barclays, Maintained "Bio-Rad Laboratories, Inc." (BIO) at Buy with Increased Target from $340 to $350 on, May 9th, 2019.

Jack, nor any peers, have made any analyst calls on BIO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources